港股異動 | 百威亞太(1876.HK)一度跌近6% 半年純利升1.7倍 但不派中期息
格隆匯7月29日丨百威亞太(1876.HK)盤中急跌近7%,現報22港元,跌幅收窄至4.32%,成交額放大至1.6億港元,總市值2910億港元。百威亞太公佈截至今年6月底止中期業績,營業額34.77億美元(下同),按年升35%。純利5.03億元,按年升171.9%;每股盈利3.8仙。但不派中期息。在中國市場,上半年銷量增加21.8%,但二季度銷量下跌4.5%,主要由於2020年疫情限制放寬致基數較高所致。在強勁的每百升收入表現帶動下,2021年第二季度的收入增加4.6%。至於印度方面,集團銷量和收入於2021年上半年及2021年第二季度均錄得雙位數增長,但仍低於2019年水平。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.